MAPT and Alzheimer disease: The relationship between tau markers of AD and tau PET imaging has been amply described by Coomas and colleagues, whose findings indicate that both plasma pTau181 and tau PET are effective in identifying Aβ pathology, but tau PET is better at monitoring disease stage and clinical progression (17).